The C-terminal domain protein (amino-acid residues 535-759) of the PB2 subunit of the RNA-dependent RNA polymerase from the highly pathogenic influenza A virus was expressed as a soluble protein in Escherichia coli and crystallized using sodium formate as a precipitant. Data sets were collected from crystals of native and selenomethionine-substituted protein on the KEK NW12 beamline at the Photon Factory and the crystals diffracted to a maximum resolution of 2.44 Å for the SeMet-derivative crystal. The native crystals were found to belong to space group P3 2 21, with unit-cell parameters a = b = 52.5, c = 156.3 Å . The Matthews value (V M ) was 2.7 Å 3 Da
The C-terminal domain protein (amino-acid residues 535-759) of the PB2 subunit of the RNA-dependent RNA polymerase from the highly pathogenic influenza A virus was expressed as a soluble protein in Escherichia coli and crystallized using sodium formate as a precipitant. Data sets were collected from crystals of native and selenomethionine-substituted protein on the KEK NW12 beamline at the Photon Factory and the crystals diffracted to a maximum resolution of 2.44 Å for the SeMet-derivative crystal. The native crystals were found to belong to space group P3 2 21, with unit-cell parameters a = b = 52.5, c = 156.3 Å . The Matthews value (V M ) was 2.7 Å 3 Da
À1
, assuming the presence of one molecule in the asymmetric unit. The SeMet-derivative crystals were found to belong to the same space group, with unit-cell parameters a = b = 52.6, c = 156.4 Å . Attempts are being made to solve the structure by multi-wavelength anomalous dispersion phasing.
Introduction
Pandemic influenza A infections have resulted in ten million deaths worldwide (Taubenberger et al., 2005) . The transcription and replication of the influenza A virus requires the activity of its RNAdependent RNA polymerase (Morse, 2007; Horimoto & Kawaoka, 2005) . The influenza A virus digests host mRNA, uses a 5 0 -RNA fragment of 10-15 nucleotides as a primer for transcription initiation (Shi et al., 1995) and possesses an RNA primer/promoter-binding activity within the C-terminal region of its RNA polymerase PB2 domain (Honda & Ishihama, 1997) . Low-resolution structures have previously been determined of the PA, PB1 and PB2 subunits of influenza A virus RNA polymerase using electron microscopy (Torreira et al., 2007) . In addition, the structures of the PB2 nuclear localization signal domain (amino-acid residues 687-759; Tarendeau et al., 2007) , of the PB2 cap (7-methylguanosine triphosphate) binding domain (amino-acid residues 318-483; Guilligay et al., 2008) and of the PA fragment with the PB1 fragment have also been reported (He et al., 2008; Obayashi et al., 2008) , but no RNA primer/ promoter-binding domain of this viral polymerase has yet been identified. It is important to determine the structure of this domain including Lys627 (the 627-region) as it may provide valuable insight for developing novel drugs against the influenza A virus. Recently, the structure of another 627-region of PB2 has been solved by Tarendeau et al. (2008) .
In order to perform X-ray crystallography of the RNA polymerase of influenza A virus, it was necessary to obtain soluble quantities of the three core subunits of the enzyme. Each individual subunit was therefore divided into three portions and the C-terminal portion of the PB2 domain (PB2 3/3; amino-acid residues 535-759) was constructed. The protein was expressed in Escherichia coli as a His 6 -tagged recombinant protein which was subsequently purified using Ni 2+ -agarose. The PB2 3/3 protein was then further purified to nearhomogeneity (98%) by cation-exchange chromatography.
The recombinant PB2 3/3 protein was subjected to crystallization. Native crystals were found to belong to space group P3 2 21, with unitcell parameters a = b = 52.5, c = 156.3 Å . The Matthews value (V M ) was 2.7 Å 3 Da À1 , assuming the presence of one molecule in the asymmetric unit. Selenomethionine-derivative crystals were obtained in the same space group, with unit-cell parameters a = b = 52.6, c = 156.4 Å . The crystal structure of PB2 3/3 is currently under analysis using multiwavelength anomalous dispersion (MAD) phasing (Hendrickson & Ogata, 1997) .
Methods and results
2.1. Plasmid construction, expression and purification of the influenza A RNA polymerase PB2 RNA primer/promoter-binding domain Influenza (A/PR/8/34) RNA polymerase PB2 plasmid, pBMSA-PB2, as deposited by Dr Susumu Nakada, was provided by the DNA Bank, RIKEN BioResource Center (Tsukuba, Japan) with the support of the National Bio-Resources Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT). cDNA fragments of the RNA primer/promoter-binding domain (PB2 3/3: amino-acid residues 535-759) of the influenza A RNA-dependent RNA polymerase PB2 subunit were amplified by PCR. The following primers were used to amplify the fragment for subcloning into a protein-expression vector: PB2 3/3 Met, GCCGTTCATATGATGT-GGGAGATTAATGGT; PB2 3/3 stop, GCCGTTGGATCCTTAAT-TGATGGCCATCCGAAT. The amplified DNA fragment was subcloned into the pET28a(+) plasmid (Novagen, Madison, Wisconsin, USA) at the NdeI and BamHI restriction sites. The construct was introduced into BL21-CodonPlus (Stratagene, La Jolla, California, USA) E. coli cells. The induction of His 6 -tagged recombinant protein expression from these constructs was achieved by the addition of isopropyl -d-1-thiogalactopyranoside (IPTG) and this was followed by purification using Ni 2+ -agarose. To prepare the cell lysate, buffer consisting of 20 mM Tris-HCl pH 7.9, 10% glycerol, 500 mM NaCl, 0.1% NP-40, 0.35% 2-mercaptoethanol, 0.1 mM phenylmethylsulfonyl fluoride (PMSF), 10 mg ml À1 leupeptin, 10 mg ml À1 pepstatin was used. For Ni 2+ -agarose chromatography, elution buffer consisting of 20 mM Tris-HCl pH 7.9, 10% glycerol, 250 mM NaCl, 0.1% NP-40, 200 mM imidazole, 0.35% 2-mercaptoethanol was used. For further purification, the His-tagged proteins were cleaved by thrombin and purified using a HiTrap CM FF column (GE Healthcare, Buckinghamshire, UK) with the Akta Prime Plus system (GE Healthcare, Buckinghamshire, UK). For CM column chromatography, buffer A (20 mM Tris-HCl pH 6.5, 10% glycerol, 50 mM NaCl) and buffer B (20 mM Tris-HCl pH 6.5, 10% glycerol, 500 mM NaCl) were used.
Crystallization
The purified samples were concentrated to 12.7 mg ml À1 (native protein) or 4.3 mg ml À1 (selenomethionine-labelled protein) by ultrafiltration. The optimal conditions for crystallization were initially determined using Crystal Screens 1 and 2 (Hampton Research, Aliso Viejo, California, USA). The searches were performed using the hanging-drop vapour-diffusion method at 277 K. The protein sample was in 10 mM Tris-HCl pH 7.5, 10% glycerol, 50 mM NaCl. 1 ml protein solution and 1 ml precipitant solution were mixed in each condition and used for crystallization. Native crystals were obtained using reservoir solutions containing 0.1 M sodium cacodylate-HCl pH 6.2, 2.2 M sodium formate (Fig. 1) and 0.1 M sodium citrate tribasic dihydrate pH 5.2, 1.8 M sodium formate. Crystals of selenomethionine-labelled PB2 3/3 protein were obtained using a reservoir solution containing 0.1 M sodium cacodylate-HCl pH 6.0, 3 M sodium formate. For the native crystal, we collected complete data to 2.7 Å resolution, although the crystal diffracted beyond 2.7 Å resolution. The SeMet-derivativized crystals were grown at a higher precipitant concentration. However, there was no great difference in diffraction quality between the native and SeMet-derivatized crystals when the same-sized crystals were used.
Preliminary X-ray diffraction analysis
Diffraction data sets for native and SeMet crystals were collected at 100 K using a mixture of Paratone-N (Hampton Research, Aliso Viejo, California, USA) and paraffin oil as a cryoprotectant and using synchrotron facility AR NW12 at the Photon Factory, Tsukuba, Japan. The image data were processed using HKL-2000 (Otwinowski & Minor, 1997) and SCALA (Collaborative Computational Project, Number 4, 1994) . The data and statistics are summarized in Table 1 . The initial phase was obtained by MAD with three-wavelength SeMet data sets using SOLVE and RESOLVE (Terwilliger, 2003) . The electron-density map showed that the structure of the PB2 3/3 protein (amino-acid residues 535-759) consists of two subdomains. The second domain is the nuclear localization signal domain described by Tarendeau et al. (2007) . The structure of this domain was fitted into the electron-density map (Fig. 2) . The first domain includes Lys627. This residue is associated with high pathogenicity and is a host-range determinant in human-to-human infection. Currently, both model building and crystallographic refinement are being carried out against a native data set. Recently, the structure of another 627-domain was reported . There are eight amino-acid differences between the two structures outside the N-terminal regions: A613T, F636L, A661T, V667I, T676I, G682S, A684S and K702R. A661T, G682S, A684S and K702R are host-range mutations from A2A (avian to avian) to H2H (human to human). A comparable study will reveal whether these host-range mutations affect the tertiary structure. The fact that two structures will be solved in different crystal forms may shed some light on artifacts arising from crystal packing.
